HAS2 and reticulum cell sarcoma: However, in histiocytic lymphoma that constitutionally does not express HAS2, when CD44 mRNA was tested upon treatment with Apixaban to explore the hyaluronan receptor expression, CD44 was reduced by drug treatment.